On March 9, 2023 Sporos BioDiscovery, Inc. (a wholly owned affiliate of Sporos Bioventures, "Sporos" or the "Company"), a precision oncology company developing a diversified pipeline of small molecule therapeutic programs targeting cancer vulnerabilities in the tumor and tumor microenvironment, reported the company’s Executive in Residence, Stephen Rubino, Ph.D., will present a company overview on Wednesday, March 15, 2023, at 12:40 p.m. ET at the Oppenheimer 33rd Annual Healthcare Conference, which will take place virtually (Press release, Sporos Bioventures, MAR 9, 2023, View Source [SID1234628427]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the live webcast of this presentation, please select this link., or visit the News & Events page of Sporos Bioventures website www.sporosbioventures.com. A replay of the webcast will be available on the website for 90 days following the event.